New Amsterdam’s Tyler Labine Shares Health Update After Blood Clot Scare

New Amsterdam star Tyler Labine just had some real-life medical drama of his own.

The actor recently spent three days in the hospital after suffering a potentially fatal blood clot, he shared on Instagram. Labine reveals that he woke up with a bad stomachache and went to the ER, and “sometimes your tummy ache turns out to be a potentially fatal blood clot in your intestines and liver and you have to spend the next 3 days in the hospital trying not to die.”

More from TVLine

• Why'd Big Sky Deny Us Any Hook-Ups? Did Feds Trot Out Trope Too Soon? Is a Just Shoot Me Revival Next? More Qs!

• Ratings: Night Court Revival Opens Big, Dominates Tuesday in Debut

• New Amsterdam EPs on Series-Finale Absence: 'We Really Did Try' to Get [Spoiler] But 'It Didn't Time Out Right'

He adds that he’s “doing alright” now: “Slow recovery, but I’m here with my family supporting me and my lovely girlfriend Martha taking care of me. I’m counting my blessings and just possibly reassessing what’s really important to me in this life.” He thanked fans for their love and support, adding a series of photos of himself being driven to the hospital in an ambulance and wearing a hospital gown. His New Amsterdam co-stars Ryan Eggold, Janet Montgomery and Anupam Kher chimed in with words of encouragement as well.

Labine played Dr. Iggy Frome on the NBC medical drama New Amsterdam, which wrapped up a five-season run earlier this year. Labine appeared in all five seasons as Dr. Frome, who headed up the hospital’s psychiatry department. His other TV credits include Reaper, Deadbeat and Animal Practice.

Best of TVLine

• 'Missing' Shows, Found! The Latest on Wheel of Time, Hacks, Transplant, Halo, Our Flag Means Death and 30+ Others

• Summer TV Calendar: Your Guide to 85+ Season and Series Premieres

• Yellowjackets Mysteries: An Up-to-Date List of the Showtime Series' Biggest Questions (and Answers?)

Get more from TVLine.com: Follow us on Twitter, Facebook, Newsletter

Click here to read the full article.